2023
Heliyon, (2023).9 10 10.1016/j.heliyon.2023.e20695.
2023
medRxiv (2023). 10.1101/2023.05.17.23290105.
2023
medRxiv (2023). 10.1101/2023.01.25.23285005.
2023
Antibiotics, (2023).12 3 10.3390/antibiotics12030460.
2023
PLoS medicine, (2023).20 7 10.1371/journal.pmed.1004250.
2023
BMC medicine, (2023).21 1 10.1186/s12916-023-02830-w.
2023
The Lancet regional health. Europe, (2023).36, 10.1016/j.lanepe.2023.100779.
Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysis.
2023
Nature communications, (2023).14 1 10.1038/s41467-023-41937-9.
epiforecasts/transformation-forecast-evaluation.
2023
, Github (2023).